Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

This publication has 54 references indexed in Scilit:

• NAB2-STAT6 fusion protein mediates cell proliferation and oncogenic progression via EGR-1 regulation
  Biochemical and Biophysical Research Communications, 2020
• Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies
  Cancer, 2020
• β‐Catenin in desmoid‐type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression
  Molecular Oncology, 2017
• Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
  European Journal of Cancer, 2016
• Characteristics of cultured desmoid cells with different CTNNB1 mutation status
  Cancer Medicine, 2015
• Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis
  Genes, Chromosomes and Cancer, 2015
• CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence
  Cancer, 2013
• Aggressive fibromatosis in children and adolescents
  Cancer, 2009
• Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: Variations with phenotype
  International Journal of Cancer, 2008
• A gene expression signature that distinguishes desmoid tumours from nodular fasciitis
  The Journal of Pathology, 2006